From: Modelling lifetime cost consequences of ReSTOR®in cataract surgery in four European countries
Spectacle dependence rates after MIOLs | Discount Rate | ||
---|---|---|---|
0% | 3% | 5% | |
France | |||
20% | -170 | -135 | -118 |
40% | -122 | -96 | -84 |
60% | -73 | -58 | -50 |
80% | -24 | -19 | -17 |
Germany | |||
20% | -209 | -166 | -145 |
40% | -149 | -119 | -104 |
60% | -89 | -71 | -62 |
80% | -30 | -24 | -21 |
Italy | |||
20% | -61 | -48 | -41 |
40% | -43 | -34 | -30 |
60% | -26 | -20 | -18 |
80% | -9 | -7 | -6 |
Spain | |||
20% | -219 | -174 | -152 |
40% | -156 | -124 | -109 |
60% | -94 | -75 | -65 |
80% | -31 | -25 | -22 |